Filtered By:
Countries: France Health
This page shows you your search results in order of date. This is page number 10.
Order by Relevance | Date
Total 729 results found since Jan 2013.
Tenecteplase in acute ischemic stroke: Review of the literature and expert consensus from the French Neurovascular Society
CONCLUSIONS: These expert consensus statements could provide a framework to guide the clinical decision-making process for the use of tenecteplase according to admission characteristics of AIS patients. However, existing data are limited, requiring inclusions in ongoing RCTs or real-life registries.PMID:36369068 | DOI:10.1016/j.neurol.2022.08.005
Source: Revue Neurologique - November 11, 2022 Category: Neurology Authors: S Olindo J-F Albucher Y Bejot J Berge C Cordonnier B Guillon D Sablot J Tardy S Alamowitch I Sibon Source Type: research
Central extracorporeal membrane oxygenation with left-ventricular vent for fulminant myocarditis: a retrospective study
ConclusionsCentral ECMO with an LV vent was effective for fulminant myocarditis refractory to percutaneous cardiopulmonary support therapy and other therapies.
Source: Journal of Artificial Organs - November 8, 2022 Category: Transplant Surgery Source Type: research
Acute stroke care in France: Survey in the 138 stroke units
CONCLUSION: There are still avenues for improvement in acute stroke care in France, especially concerning the number and regional repartition of I-SU beds, and access to reperfusion therapies.PMID:36336492 | DOI:10.1016/j.neurol.2022.07.010
Source: Revue Neurologique - November 6, 2022 Category: Neurology Authors: D Leys A Falcou J-L Mas Source Type: research
Comparative Effectiveness and Safety Between Apixaban, Dabigatran, Edoxaban, and Rivaroxaban Among Patients With Atrial Fibrillation : A Multinational Population-Based Cohort Study
CONCLUSION: Among patients with AF, apixaban use was associated with lower risk for GIB and similar rates of ischemic stroke or systemic embolism, ICH, and all-cause mortality compared with dabigatran, edoxaban, and rivaroxaban. This finding was consistent for patients aged 80 years or older and those with chronic kidney disease, who are often underrepresented in clinical trials.PRIMARY FUNDING SOURCE: None.PMID:36315950 | DOI:10.7326/M22-0511
Source: Annals of Internal Medicine - October 31, 2022 Category: Internal Medicine Authors: Wallis C Y Lau Carmen Olga Torre Kenneth K C Man Henry Morgan Stewart Sarah Seager Mui Van Zandt Christian Reich Jing Li Jack Brewster Gregory Y H Lip Aroon D Hingorani Li Wei Ian C K Wong Source Type: research
Impact of Smoking on Functional Prognosis after Ischemic Stroke according to Deprivation: A Prospective Cohort Study
Conclusion: The effect of smoking on functional prognosis after ischemic stroke varied according to deprivation status, with poorer outcomes observed in nondeprived patients.Neuroepidemiology
Source: Neuroepidemiology - October 27, 2022 Category: Epidemiology Source Type: research
Days spent at home and mortality after critical illness: a cluster analysis using nationwide data
Chest. 2022 Oct 15:S0012-3692(22)03997-6. doi: 10.1016/j.chest.2022.10.008. Online ahead of print.ABSTRACTBACKGROUND: Beyond the question of short-term survival, days spent at home could be considered a patient-centered outcome in critical care trials.RESEARCH QUESTION: What are the days spent at home and healthcare trajectories during the year after surviving critical illness?STUDY DESIGN AND METHODS: Data were extracted on adult survivors spending at least two nights in a French intensive care unit (ICU) during 2018 who were treated with invasive mechanical ventilation and/or vasopressors or inotropes. Trauma, burn, orga...
Source: Chest - October 18, 2022 Category: Respiratory Medicine Authors: Guillaume L Martin Alice Atramont Marjorie Mazars Ayden Tajahmady Emin Agamaliyev Mervyn Singer Marc Leone Matthieu Legrand Source Type: research
Comparative non-persistence in the first year of treatment with oral anticoagulants in patients with atrial fibrillation: A French comprehensive nationwide study
CONCLUSIONS: In this nationwide observational study, non-persistence rates of oral anticoagulant treatment were high in patients treated for NVAF. Apixaban-treated patients seem to experience lowest discontinuation rates 12 months after treatment initiation compared to patients treated with any other OAC.PMID:36257903 | DOI:10.1016/j.acvd.2022.06.006
Source: Archives of Cardiovascular Diseases - October 18, 2022 Category: Cardiology Authors: Nicolas Danchin Gabriel Steg Isabelle Mah é Olivier Hanon Flore Jacoud Ma ëva Nolin Faustine Dalon Fran çois-Emery Cotte Sabrina Gollety Eric Van Ganse Manon Belhassen Source Type: research
